Recent studies revealed alterations in mitochondrial fission and fusion, due to increased Aβ peptide interaction with the mitochondrial protein Drp 1 [19] , inducing increased mitochondrial fragmentation, impaired axonal transport of mitochondria, synaptic degeneration [20] and activation of apoptotic process, given that mitochondria fission and fusion are critical processes for mitochondrial health [21] . In addition, over expression of tau protein inhibits kinesin-dependent trafficking of mitochondria, clustering them in the perikaryon [22] , decreasing the number of dendritic and synaptic mitochondria with serious consequences on synaptic plasticity [23, 24] , since mitochondrial transport has a high impact on synaptic homeostasis [25] . Normally mitochondrial motility and accumulation are harmoniously coordinated, since mitochondria are mainly transported to regions where the necessity for energy production and consume is particularly high, as it occurs in the synapses, which have high energy demand, for maintaining neuronal communication [26] .
Therapeutic strategies targeting mitochondria may be beneficial in the initial stages of Alzheimer's disease. Thus protection to mitochondria by inhibition of mitochondrial β-oxidation [27] , and therapeutic application of mitochondrial enhancers and molecules supporting the Electron Transport Chain (ETC) might play a positive role in a prodromal stage of Alzheimer's disease [28] . In experimental level modulation of mitochondrial complex I activity proved to be beneficial in multiple animal models of familial Alzheimer's disease [29] . Blockade of Cyclophilin D, which is a part of the mitochondrial permeability transition pore, may enlarge the therapeutic perspectives at the initial stage of Alzheimer's disease [30] . Controlling mitophagy may also ameliorate the clinical phenomena in some phenotypes of Alzheimer's disease [31] .
In the spectrum of nanotechnology [32] mitochondria-targeting ceria nanoparticles as antioxidants may be beneficial in Alzheimer's disease [33] .
In the ongoing research and the continuous endeavors to contribute therapeutically in Alzheimer's disease mitochondria remain a strategic point in the field.
